Serum osteocalcin levels in patients with nonalcoholic fatty liver disease: Association with ballooning degeneration

References

• Erickson SK. Nonalcoholic fatty liver disease. J Lipid Res 2009;50:S412–6.
   PubMed Web of Science ®Google Scholar
• Sass DA, Chang P, Chopra KB. Nonalcoholic fatty liver disease: a clinical review. Dig Dis Sci 2005;50:171–80.
   PubMed Web of Science ®Google Scholar
• Almeda-Valdés P, Cuevas-Ramos D, Aguilar-Salinas CA. Metabolic syndrome and non-alcoholic fatty liver disease. Ann Hepatol 2009;8:S18–24.
   PubMed Web of Science ®Google Scholar
• Byrne CD, Olufadi R, Bruce KD, Cagampang FR, Ahmed MH. Metabolic disturbances in non-alcoholic fatty liver disease. Clin Sci (Lond) 2009;116:539–64.
   PubMed Web of Science ®Google Scholar
• Grønbaek H, Thomsen KL, Rungby J, Schmitz O, Vilstrup H. Role of nonalcoholic fatty liver disease in the development of insulin resistance and diabetes. Expert Rev Gastroenterol Hepatol 2008;2:705–11.
   PubMedGoogle Scholar
• Yilmaz Y, Ulukaya E, Gul OO, Arabul M, Gul CB, Atug O, Oral AY, Aker S, Dolar E. Decreased plasma levels of soluble receptor for advanced glycation endproducts (sRAGE) in patients with nonalcoholic fatty liver disease. Clin Biochem 2009;42:802–7.
   PubMedGoogle Scholar
• Lee AJ, Hodges S, Eastell R. Measurement of osteocalcin. Ann Clin Biochem 2000;37:432–46.
   PubMed Web of Science ®Google Scholar
• Kim YS, Paik IY, Rhie YJ, Suh SH. Integrative physiology: defined novel metabolic roles of osteocalcin. J Korean Med Sci 2010;25:985–91.
   PubMedGoogle Scholar
• Lieben L, Callewaert F, Bouillon R. Bone and metabolism: a complex crosstalk. Horm Res 2009;71(Suppl. 1):134–8.
   PubMedGoogle Scholar
• Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, Zhang Z, Kim JK, Mauvais-Jarvis F, Ducy P, Karsenty G. Endocrine regulation of energy metabolism by the skeleton. Cell 2007;130:456–69.
   PubMed Web of Science ®Google Scholar
• Fernández-Real JM, Izquierdo M, Ortega F, Gorostiaga E, Gómez-Ambrosi J, Moreno-Navarrete JM, Frühbeck G, Martínez C, Idoate F, Salvador J, Forga L, Ricart W, Ibañez J. The relationship of serum osteocalcin concentration to insulin secretion, sensitivity, and disposal with hypocaloric diet and resistance training. J Clin Endocrinol Metab 2009;94:237–45.
   PubMed Web of Science ®Google Scholar
• Pittas AG, Harris SS, Eliades M, Stark P, Dawson-Hughes B. Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab 2009;94: 827–32.
   PubMed Web of Science ®Google Scholar
• Kindblom JM, Ohlsson C, Ljunggren O, Karlsson MK, Tivesten A, Smith U, Mellström D. Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men. J Bone Miner Res 2009;24:785–91.
   PubMed Web of Science ®Google Scholar
• Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Kurioka S, Yano S, Sugimoto T. Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab 2009;94:45–9.
   PubMed Web of Science ®Google Scholar
• Saleem U, Mosley Jr TH, Kullo IJ. Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome. Arterioscler Thromb Vasc Biol 2010;30:1474–8.
   PubMed Web of Science ®Google Scholar
• Szalay F, Lakatos P, Németh J, Abonyi M, Büki B, Tarján G, Holló I. [Decreased serum osteocalcin level in non-alcoholic and alcoholic chronic liver diseases]. Orv Hetil 1991;132: 1301–5.
   PubMedGoogle Scholar
• Fernández-Real JM, Ortega F, Gómez-Ambrosi J, Salvador J, Frühbeck G, Ricart W. Circulating osteocalcin concentrations are associated with parameters of liver fat infiltration and increase in parallel to decreased liver enzymes after weight loss. Osteoporos Int 2010;21:2101–7.
   PubMedGoogle Scholar
• ACE/ADA Task Force on Inpatient Diabetes. American College of Endocrinology and American Diabetes Association Consensus statement on inpatient diabetes and glycemic control. Diabetes Care 2006;29:1955–62.
   PubMed Web of Science ®Google Scholar
• Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C; American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004;109:433–8.
   PubMed Web of Science ®Google Scholar
• Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ; Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41: 1313–21.
   PubMed Web of Science ®Google Scholar
• Kassi E, Papavassiliou AG. A possible role of osteocalcin in the regulation of insulin secretion: human in vivo evidence? J Endocrinol 2008;199:151–3.
   PubMedGoogle Scholar
• Fujii H, Ikura Y, Arimoto J, Sugioka K, Iezzoni JC, Park SH, Naruko T, Itabe H, Kawada N, Caldwell SH, Ueda M. Expression of perilipin and adipophilin in nonalcoholic fatty liver disease; relevance to oxidative injury and hepatocyte ballooning. J Atheroscler Thromb 2009;16:893–901.
   PubMed Web of Science ®Google Scholar
• Caldwell S, Ikura Y, Dias D, Isomoto K, Yabu A, Moskaluk C, Pramoonjago P, Simmons W, Scruggs H, Rosenbaum N, Wilkinson T, Toms P, Argo CK, Al-Osaimi AM, Redick JA. Hepatocellular ballooning in NASH. J Hepatol 2010;53: 719–23.
   PubMed Web of Science ®Google Scholar
• Hwang YC, Jeong IK, Ahn KJ, Chung HY. The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced β-cell function in middle-aged male subjects. Diabetes Metab Res Rev 2009;25:768–72.
   PubMed Web of Science ®Google Scholar
• Shea MK, Gundberg CM, Meigs JB, Dallal GE, Saltzman E, Yoshida M, Jacques PF, Booth SL. Gamma-carboxylation of osteocalcin and insulin resistance in older men and women. Am J Clin Nutr 2009;90:1230–5.
   PubMed Web of Science ®Google Scholar
• Emanuele E. Is biopsy always necessary? Toward a clinico-laboratory approach for diagnosing nonalcoholic steatohepatitis in obesity. Hepatology 2008;48:2086–7.
   PubMed Web of Science ®Google Scholar
• Yilmaz Y, Dolar E. Biomarkers for noninvasive biochemical diagnosis of nonalcoholic steatohepatitis: tools or decorations? World J Gastroenterol 2009;15:4346–7.
   PubMedGoogle Scholar